Phase 3 Chronic Hepatitis B Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
Chronic Hepatitis B With Hepatic Fibrosis
Beijing Continent Pharmaceutical Co, Ltd.300 enrolled1 locationNCT07343778
Recruiting
Phase 3
A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
Chronic Hepatitis BAzvudine
Zhigang Ren120 enrolled1 locationNCT07307586
Not Yet Recruiting
Phase 3
Tenofovir versus Adefovir for the treatment of HBeAg negative chronic hepatitis B
HBeAg negative Chronic Hepatitis B
Gilead Sciences Inc300 enrolled1 locationACTRN12605000029695
Not Yet Recruiting
Phase 3
Tenofovir versus Adefovir for the treatment of HBeAg positive chronic hepatitis B
HBeAg positive chronic hepatitis B
Gilead Sciences Inc240 enrolled1 locationACTRN12605000028606